Substantia nigra hyperechogenicity in healthy controls: A [ 18Fluoro] Dopa-PET follow-up study

Journal of Neurology

Volumn 260, Issue 7, 2013, Pages 1907-1911

  Schroeder, Ute ^a   Behnke, Stefanie ^a   Buchholz, Hans Georg ^b   Fassbender, Klaus ^a   Schreckenberger, Matthias ^b   Berg, Daniela ^c  

^a SAARLAND UNIVERSITY   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

18Fluoro Dopa PET; Parkinson's disease; Substantia nigra hyperechogenicity; Transcranial ultrasound

Indexed keywords

DOPA; DOPA FL18; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DOPAMINE UPTAKE; FEMALE; FOLLOW UP; HUMAN; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NORMAL HUMAN; OUTCOME ASSESSMENT; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SUBSTANTIA NIGRA; TELECONSULTATION;

ADULT; AGED; DIHYDROXYPHENYLALANINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROLOGIC EXAMINATION; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SUBSTANTIA NIGRA;

EID: 84880282659     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-013-6904-4     Document Type: Article

References (8)

1. Walter U, Wittstock M, Benecke R, Dressler D (2002) Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 109:191-196
2. Berg D, Becker G, Zeiler B, Tucha O, Hofmann E, Preier M et al (1999) Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 53:1026-1031
3. Behnke S, Schroeder U, Berg D (2010) Transcranial sonography in the premotor diagnosis of Parkinson's disease. Int Rev Neurobiol 90:93-106
4. Behnke S, Schröder U, Dillmann U, Buchholz HG, Schreckenberger M, Fuss G et al (2009) Hyperechogenicity of the substantia nigra in healthy controls is related to MRI changes and to neuronal loss as determined by F-Dopa PET. Neuroimage 47:1237-1243
5. Berg D, Roggendorf W, Schröder U, Klein R, Tatschner T, Benz P et al (2002) Echogenicity of the substantia nigra. Association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 59:999-1005
6. Baum E, Eggert K (2004) Frühes Erkennen von Morbus Parkinson. Der Hausarzt 12:44-47
7. Hilker R, Klein C, Hedrich K, Ozelius LJ, Vieregge P, Herholz K et al (2002) The striatal dopaminergic deficit is dependent on the number of mutant alleles in a family with mutations in the parkin gene: evidence for enzymatic parkin function in humans. Neurosci Lett 323:50-54
8. Vingerhoets FJ, Snow BJ, Lee CS, Schulzer M, Mak E, Calne DB (1994) Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism. Ann Neurol 36:759-764